These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10215864)

  • 21. Expression and pharmacological characterization of the human mu-opioid receptor in the methylotrophic yeast Pichia pastoris.
    Talmont F; Sidobre S; Demange P; Milon A; Emorine LJ
    FEBS Lett; 1996 Oct; 394(3):268-72. PubMed ID: 8830656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
    Liu-Chen LY; Yang HH; Li S; Adams JU
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor.
    Emmerson PJ; Clark MJ; Mansour A; Akil H; Woods JH; Medzihradsky F
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1121-7. PubMed ID: 8819494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guanine nucleotide-binding protein-coupled and -uncoupled states of opioid receptors and their relevance to the determination of subtypes.
    Richardson A; Demoliou-Mason C; Barnard EA
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10198-202. PubMed ID: 1332034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opioid peptide receptor studies. 7. The methylfentanyl congener RTI-4614-4 and its four enantiomers bind to different domains of the rat mu opioid receptor.
    Lu YF; Xu H; Liu-Chen LY; Chen C; Partilla JS; Brine GA; Carroll FI; Rice KC; Lai J; Porreca F; Sadee W; Rothman RB
    Synapse; 1998 Feb; 28(2):117-24. PubMed ID: 9450512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Naloxone activation of mu-opioid receptors mutated at a histidine residue lining the opioid binding cavity.
    Spivak CE; Beglan CL; Seidleck BK; Hirshbein LD; Blaschak CJ; Uhl GR; Surratt CK
    Mol Pharmacol; 1997 Dec; 52(6):983-92. PubMed ID: 9415708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alteration of the interaction of mu-opioid receptor and G protein after chronic PL017 treatment in rats.
    Tao PL; Lue WM; Lee CR; Chang LR
    Chin J Physiol; 1995; 38(3):193-9. PubMed ID: 8846729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo opiate receptor binding of oripavines to mu, delta and kappa sites in rat brain as determined by an ex vivo labeling method.
    Richards ML; Sadée W
    Eur J Pharmacol; 1985 Aug; 114(3):343-53. PubMed ID: 2998812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opioid agonist and antagonist treatment differentially regulates immunoreactive mu-opioid receptors and dynamin-2 in vivo.
    Yoburn BC; Purohit V; Patel K; Zhang Q
    Eur J Pharmacol; 2004 Sep; 498(1-3):87-96. PubMed ID: 15363980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential regulation of two molecular forms of a mu-opioid receptor type by sodium ions, manganese ions and by guanyl-5'-yl imidodiphosphate.
    Jauzac P; Frances B; Puget A; Moisand C; Meunier JC
    J Recept Res; 1986; 6(1):1-25. PubMed ID: 3012080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opioid binding sites in the guinea pig and rat kidney: radioligand homogenate binding and autoradiography.
    Dissanayake VU; Hughes J; Hunter JC
    Mol Pharmacol; 1991 Jul; 40(1):93-100. PubMed ID: 1649966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes.
    Puttfarcken P; Werling LL; Brown SR; Cote TE; Cox BM
    Mol Pharmacol; 1986 Aug; 30(2):81-9. PubMed ID: 3016503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the relative efficacy and potency of mu-opioid agonists to activate Galpha(i/o) proteins containing a pertussis toxin-insensitive mutation.
    Clark MJ; Furman CA; Gilson TD; Traynor JR
    J Pharmacol Exp Ther; 2006 May; 317(2):858-64. PubMed ID: 16436499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Agonist activation of delta-opioid receptor but not mu-opioid receptor potentiates fetal calf serum or tyrosine kinase receptor-mediated cell proliferation in a cell-line-specific manner.
    Law PY; McGinn TM; Campbell KM; Erickson LE; Loh HH
    Mol Pharmacol; 1997 Jan; 51(1):152-60. PubMed ID: 9016358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative pharmacological properties and functional coupling of mu and delta opioid receptor sites in human neuroblastoma SH-SY5Y cells.
    Kazmi SM; Mishra RK
    Mol Pharmacol; 1987 Jul; 32(1):109-18. PubMed ID: 3037297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delta and mu opioid receptors from the brain of a urodele amphibian, the rough-skinned newt Taricha granulosa: cloning, heterologous expression, and pharmacological characterization.
    Bradford CS; Walthers EA; Stanley DJ; Baugh MM; Moore FL
    Gen Comp Endocrinol; 2006 May; 146(3):275-90. PubMed ID: 16375901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different subtypes of opioid receptors have different affinities for G-proteins.
    Polastron J; Jauzac P
    Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):389-401. PubMed ID: 7920183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversible modulation of opioid receptor binding in intact neural cells by endogenous guanosine triphosphate.
    Yabaluri N; Medzihradsky F
    Mol Pharmacol; 1995 Oct; 48(4):690-5. PubMed ID: 7476895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding properties of C-truncated delta opioid receptors.
    Wang CH; Zhou DH; Chen J; Li GE; Pei G; Chi ZQ
    Zhongguo Yao Li Xue Bao; 1997 Jul; 18(4):337-40. PubMed ID: 10072917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spinal opioid mu receptor expression in lumbar spinal cord of rats following nerve injury.
    Porreca F; Tang QB; Bian D; Riedl M; Elde R; Lai J
    Brain Res; 1998 Jun; 795(1-2):197-203. PubMed ID: 9622629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.